Yi Kathy 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Feb 5, 2021
Insider Transaction Report
Form 4
Yi Kathy
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-03+216,718→ 216,718 totalExercise: $12.70Exp: 2031-02-03→ Common Stock (216,718 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on February 3, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.